- Report
- June 2021
- 73 Pages
Middle East, Africa
From €1434EUR$1,500USD£1,232GBP
- Report
- December 2020
Global
From €7170EUR$7,500USD£6,162GBP
From €3346EUR$3,500USD£2,875GBP
- Report
- September 2023
- 109 Pages
Global
From €3500EUR$3,922USD£3,113GBP
- Report
- May 2021
- 95 Pages
Global
From €3200EUR$3,586USD£2,846GBP
- Report
- May 2023
- 113 Pages
Global
From €3500EUR$3,922USD£3,113GBP
The High Flow Nasal Cannula (HFNC) is a respiratory device used to deliver humidified oxygen or air to a patient. It is a non-invasive form of respiratory support that is used to treat patients with respiratory distress. The device consists of a nasal cannula connected to a flow generator, which is used to regulate the flow of oxygen or air. The device is designed to provide a higher flow rate than traditional nasal cannulas, allowing for improved oxygen delivery and improved patient comfort.
HFNC is used in a variety of clinical settings, including emergency departments, intensive care units, and home care settings. It is used to treat a variety of respiratory conditions, including chronic obstructive pulmonary disease, asthma, and acute respiratory distress syndrome.
The HFNC market is a rapidly growing segment of the respiratory device market. It is expected to continue to grow as more healthcare providers recognize the benefits of HFNC in treating respiratory conditions.
Some companies in the HFNC market include Fisher & Paykel Healthcare, Philips Respironics, Vapotherm, and ResMed. Show Less Read more